Today archaeologists unearthed a 'Black Death' grave in London, containing more than a dozen skeletons of people suspected to have died from the plague. The victims are thought to have died during the 14th century and archaeologists anticipate finding many more as they excavate the site.
The Plague is by definition a re-emerging infectious disease which affects the lungs and is highly contagious, leading to mass outbreaks across populations. History shows us that population levels suffered globally due to the plague, with around 75 million people globally perishing during the 14th century Black Death.
This study, published in Infection, Genetics and Evolution, analysed the Great Plague of Marseille, which caused 100,000 deaths between 1720 and 1723. The researchers aimed to highlight issues we are facing with infectious diseases today, to identify the best ways to respond to epidemics and whether we are still at risk of the plague re-emerging again.
Results show that a number of factors show we are still at risk of plague today. This is largely due to transport trade and novel threats in developing countries where multi-drug resistant pathogens are currently emerging and spreading rapidly. This genetic change has also contributed to a development in the way the bacteria infect new hosts meaning they can now live in mammalian blood.
The study also highlighted the need for effective management of epidemics in future. Fear of in infection can have a negative impact on a population's economic situation due to a significant loss of tourism, and widespread panic. History has shown us that providing the necessary information about diseases and improving the management of epidemics are vital steps for avoiding panic and containing diseases.
Notes for editors
This article is "Small oversights that led to the Great Plague of Marseille (1720 - 1723): Lessons from the past" by Christian A. Devaux (DOI: 10.1016/j.meegid.2012.11.016,) and appears in Infection, Genetics and Evolution published by Elsevier.
The article is available to credentialed journalists at no charge through free access to ScienceDirect, the world's largest repository of scientific information. Please use your ScienceDirect media login and password to access the full text research paper. For a new media login, forgotten password or if you have any specific questions, please contact firstname.lastname@example.org.
If you are a credentialed journalist and are interested in receiving other research alerts from Elsevier, please sign up for Elsevier's Monthly Research Selection (EMRS) - a monthly email developed by the Elsevier Newsroom which highlights new, interesting, interesting or otherwise intriguing research articles for health and science media. The full text research articles included are peer reviewed and have been publicly available for no more than 4-6 weeks (they are usually articles-in-press). They have not been press-released nor covered in the media (that we are aware of) and they are not embargoed.
If you would like to sign up for the EMRS please send an email to email@example.com.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.